Clinical Trial Detail

NCT ID NCT00700882
Title Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By Surgery
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Eastern Cooperative Oncology Group
Indications

melanoma

Therapies

Dasatinib

Age Groups: adult

No variant requirements are available.